Comparison of the effects of an ampakine with those of methamphetamine on aggregate neuronal activity in cortex versus striatum

Molecular Brain Research

Volumn 46, Issue 1-2, 1997, Pages 127-135

  Palmer, Linda C ^a   Hess, Ursula S ^b   Larson, John ^a   Rogers, Gary A ^c   Gall, Christine M ^a,b   Lynch, Gary ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

c fos; In situ hybridization; Motor cortex; Orbitofrontal cortex; Schizophrenia; Somatosensory cortex

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; HIPPOCAMPUS; MOTOR CORTEX; NERVE GROWTH; NONHUMAN; ORBITAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SOMATOSENSORY CORTEX;

ANIMALS; CEREBRAL CORTEX; GENE EXPRESSION; GENES, FOS; IN SITU HYBRIDIZATION; MALE; METHAMPHETAMINE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RNA, MESSENGER; VISUAL CORTEX;

EID: 0030924239     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00280-X     Document Type: Article

References (47)

1. Alexander, G.E. and Crutcher, M.D., Functional architecture of basal ganglia circuits: neural substrates of parallel processing, Trends Neurosci., 13 (1990) 266-271.
2. Allen, R.M. and Young, S.J., Phencyclidine-induced psychosis, Am. J. Psychiatry, 135 (1978) 1081-1085.
3. Arai, A., Kessler, M., Ambros-Ingerson, J., Rogers, G. and Lynch, G., A centrally active drug that modulates AMPA receptor gated currents, Brain Res., 638 (1994) 343-346.
4. Arai, A., Kessler, M., Rogers, G. and Lynch, G., Effects of a memory enhancing drug on AMPA receptor currents and synaptic transmission in hippocampus, J. Pharmacol. Exp. Ther., 278 (1996) 627-638.
5. Benes, F.M. and Bird, E.D., An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients, Arch. Gen. Psychiatry, (1987) 608-616.
6. Benes, F.M., Davidson, J. and Bird, E.D., Quantitative cytoarchitectural studies of cerebral cortex of schizophrenics, Arch. Gen. Psychiatry, 43 (1986) 31-35.
7. Berendse, H.W., Galis-deGraaf, Y. and Groenewegen, H.J., Topographical organization and relationship with the ventral striatal compartments of prefrontal corticostriatal projections in the rat, J. Comp. Neurol., 316 (1992) 314-347.
8. Bogerts, B., Meertz, E. and Schonfeldt-Bausch, R., Basal ganglia and limbic system pathology in schizophrenia: a morphometric study of brain volume and shrinkage, Arch. Gen. Psychiatry, 42 (1985) 784-791.
9. Carlsson, M. and Carlsson, A., Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease, Trends Neurosci., 13 (1990) 272-276.
10. Clineschmidt, B.V., Martin, G.E., Bunting, P.R. and Papp, N.L., Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5-H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties, Drug Dev. Res., 2 (1982) 135-145.
11. Creese, I., Burt, D.R. and Snyder, S.H., Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs, Science, 192 (1976) 481-482.
12. Crow, T.J., Johnstone, E.C., Deakin, J.F. and Longden, A., Dopamine and schizophrenia, Lancet, 2 (1976) 563-566.
13. Curran, T., Gordon, M.B., Rubino, K.L. and Sambucetti, L.C., Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modification in vitro, Oncogene, 2 (1987) 79-84.
14. Eastwood, S.L., McDonald, B., Burnet, P.W.J., Beckwith, J.P., Kerwin, R.W. and Harrison, P.J., Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia, Mol. Brain Res., 29 (1995) 211-223.
15. Falkai, P., Bogerts, B. and Rozumek, M., Cell loss and volume reduction in the entorhinal cortex of schizophrenics, Biol. Psychiatry, (1988) 515-521.
16. Francis, P., Sims, N., Procter, A. and Bowen, D., Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives, J. Neurochem., 60 (1993) 1589-1604.
17. Freed, W.J., Weinberger, D.R., Bing, L.A. and Wyatt, R.J., Neuropharmacological studies of phencyclidine (PCP)-induced behavioral stimulation in mice, Psychopharmacology, 71 (1980) 291-297.
18. Gall, C., Murray, K. and Isackson, P.J., Kainic acid-induced seizures stimulate increased expression of nerve growth factor mRNA in rat hippocampus, Mol. Brain Res., 9 (1991) 113-123.
19. Gall, C.M., Berschauer, R. and Isackson, P.J., Seizures increase basic fibroblast growth factor mRNA in adult rat forebrain neurons and glia, Mol. Brain Res., 21 (1994) 190-205.
20. Gerfen, C., The neostriatal mosaic: multiple levels of compartmental organization, Trends Neurosci., 15 (1992) 133-139.
21. Gerfen, C.R., The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination, Science, 246 (1989) 385-388.
22. Gold, S., Hennegriff, M., Lynch, G. and Gall, C.M., Relative concentrations and seizure-induced changes in mRNAs encoding three AMPA receptor subunits in hippocampus and cortex, J. Comp. Neurol., 365 (1996) 541-555.
23. Goldberg, T.E., Berman, K.F. and Weinberger, D.R., An orientation to work on the prefrontal cortex in schizophrenia. In S.C. Schulz and C.A. Tamminga (Eds.), Schizophrenia: Scientific Progress, Oxford University Press, New York, 1989, pp. 227-246.
24. Granger, R., Deadwyler, S., Davis, M., Moskovitz, B., Kessler, M., Rogers, G. and Lynch, G., Facilitation of glutamate receptors reverses an age-associated memory impairment in rats, Synapse, 22 (1996) 332-337.
25. Graybiel, A.M., Moratalla, R. and Robertson, H.A., Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum, Proc. Natl. Acad. Sci. USA, 87 (1990) 6912-6916.
26. Hess, U.S., Lynch, G. and Gall, C.M., Changes in c-fos mRNA expression in rat brain during odor discrimination learning: Differential involvement of hippocampal subfields CA1 and CA3, J. Neurosci., 15 (1995a) 4786-4795.
27. Hess, U.S., Lynch, G. and Gall, C.M., Regional patterns of c-fos mRNA expression in rat hippocampus following exploration of a novel environment versus performance of a well-learned discrimination, J. Neurosci., 15 (1995b) 7796-7809.
28. Ingvar, D.H., Evidence for frontal/prefrontal cortical dysfunction in chronic schizophrenia: the phenomenon of 'hypofrontality' reconsidered. In H. Helmchen and F.A. Henn (Eds.), Biological Perspectives of Schizophrenia, Wiley, New York, 1987, pp. 201-211.
29. Jaber, M., Cador, M., Dumartin, B., Normand, E., Stinus, L. and Bloch, B., Acute and chronic amphetamine treatments differentially regulate neuropeptide messenger RNA levels and Fos immuno-reactivity in rat striatal neurons, Neuroscience, 65 (1995) 1041-1050.
30. Johnson, S.A., Larson, J., Luu, N.T., Lutz, D.L., Rogers, G. and Lynch, G., Antagonism of methamphetamine-induced hyperactivity in rats by specific facilitation of AMPA-receptor-mediated glutamatergic transmission, Soc. Neurosci. Abstr., (1996) 1676.
31. Larson, J., Quach, C.N., LeDuc, B., Nguyen, A., Rogers, G.A. and Lynch, G., Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats, Brain Res., 738 (1996) 353-356.
32. Lauterborn, J.C., Isackson, P.J., Montalvo, R. and Gall, C.M., In situ hybridization localization of choline acetyltransferase mRNA in adult rat brain and spinal cord, Mol. Brain Res., 17 (1993) 59-69.
33. Le Moine, C. and Bloch, B., D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum, J. Comp. Neurol., 355 (1995) 418-426.
34. McGeorge, A.J. and Faull, R.L.M., The organization of the projection from the cerebral cortex to the striatum in the rat, Neuroscience, 29 (1989) 503-537.
35. McKinney, W.T., Animal models of schizophrenic disorders. In S.C. Schulz and C.A. Tamminga (Eds.), Schizophrenia: Scientific Progress, Oxford University Press, New York, 1989, pp. 141-154.
36. Morgan, J.I. and Curran, T., Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun, Annu. Rev. Neurosci., 14 (1991) 421-51.
37. Nguyen, T.V., Kosofsky, B.E., Birnbaum, R., Cohen, B.M. and Hyman, S.E., Differential expression of c-fos and Zif268 in rat striatum after haloperidol, clozapine, and amphetamine, Proc. Natl. Acad. Sci. USA, 89 (1992) 4270-4274.
38. Riederer, P., Lange, K.W., Kornhuber, J. and Danielczyk, W., Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia, Arzneimittel-Forschung, 42 (1992) 265-268.
39. Shin, C., McNamara, J.O., Morgan, J.I., Curran, T. and Cohen, D.R., Induction of c-fos mRNA expression by afterdischarge in the hippocampus of naive and kindled rats, J. Neurochem., 55 (1990) 1050-1055.
40. Sirvio, J., Larson, J., Quach, C.N., Rogers, G.A. and Lynch, G., Effects of pharmacologically facilitating glutamatergic transmission in the trisynaptic intrahippocampal circuit, Neuroscience, 74 (1996) 1025-1035.
41. Snyder, S.H., Amphetamine psychosis: a 'model' schizophrenia mediated by catecholamines, Am. J. Psychiatry, 130 (1973) 61-67.
42. Staubli, U., Perez, Y., Xu, F., Rogers, G., Ingvar, M., Stone-Elander, S. and Lynch, G., Centrally active modulators of glutamate (AMPA) receptors facilitate the induction of LTP in vivo, Proc. Natl. Acad. Sci. USA, 91 (1994) 11158-11162.
43. Staubli, U., Rogers, G. and Lynch, G., Facilitation of glutamate receptors enhances memory, Proc. Natl. Acad. Sci. USA, 91 (1994) 777-781.
44. Swanson, L., Brain Maps: Structure of the Rat Brain, Elsevier, New York, 1992.
45. Tiedtke, P.I., Bischoff, C. and Schmidt, W.J., MK-801-induced stereotypy and its antagonism by neuroleptic drugs, J. Neural Transm. - Gen. Sect., 81 (1990) 173-182.
46. Wachtel, H. and Turski, L., Glutamate: a new target in schizophrenia? Trends Pharmacol. Sci., 11 (1990) 219-220.
47. Weinberger, D.R., Berman, K.F. and Illowsky, B., Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism, Arch. Gen. Psychiatry, 45 (1988) 609-615.